Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

185.22
Delayed Data
As of Jul 02
 +1.36 / +0.74%
Today’s Change
150.06
Today|||52-Week Range
203.30
+0.10%
Year-to-Date

Today’s Trading

Previous close183.86
Today’s open184.00
Day’s range183.18 - 185.25
Volume1,501,802
Average volume (3 months)2,142,011
Market cap$41.8B
Dividend yield--
Data as of 3:59pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)+156.69%
Earnings growth (this year)-2.53%
Earnings growth (next 5 years)+19.69%
Revenue growth (last year)+46.49%
P/E ratio63.4
Price/Sales16.84
Price/Book11.17

Competitors

 Today’s
change
Today’s
% change
SHPGShire+2.54+1.04%
MYLMylan NV+0.42+0.60%
VRTXVertex Pharmaceutica...+5.07+4.02%
PRGOPerrigo Company PLC-1.38-0.75%
Data as of 4:14pm ET, 07/02/2015

Financials

Next reporting dateJuly 23, 2015
EPS forecast (this quarter)$1.39
Annual revenue (last year)$2.2B
Annual profit (last year)$656.9M
Net profit margin29.66%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
David L. Hallal
Chief Financial Officer &
Executive Vice President
Vikas Sinha
Corporate headquarters
Cheshire, Connecticut

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers